Real‐world safety and efficacy of sofosbuvir and ledipasvir for elderly patients

BACKGROUND AND AIM: In September 2015, sofosbuvir and ledipasvir were approved for clinical use in Japan for patients infected with genotype 1 hepatitis C virus. We conducted a postmarketing prospective cohort study to elucidate the safety and efficacy of this therapy in a real‐world setting. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamai, Hideyuki, Shingaki, Naoki, Ida, Yoshiyuki, Shimizu, Ryo, Maeshima, Shuya, Okamura, Junpei, Kawashima, Akira, Nakao, Taisei, Hara, Takeshi, Matsutani, Hiroyoshi, Nishikawa, Izumi, Higashi, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308062/
https://www.ncbi.nlm.nih.gov/pubmed/30619941
http://dx.doi.org/10.1002/jgh3.12088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308062/
https://www.ncbi.nlm.nih.gov/pubmed/30619941
http://dx.doi.org/10.1002/jgh3.12088

Ejemplares similares